Logo for MorphoSys AG

MorphoSys Investor Relations Material

Latest events

Logo for MorphoSys AG

Q4 2023

MorphoSys
Logo for MorphoSys

Q1 2024

30 Apr, 2024
Logo for MorphoSys

Q4 2023

14 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from MorphoSys AG

Access all reports
Segment Data
Access more data
Revenue by
Source
Royalties
Licenses, Milestones and Other
Product Sales
Expenses by
Financials
MorphoSys AG is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. It offers MOR101 for the treatment of acute lymphoblastic leukemia. The company was founded in 1992 and is headquartered in Planegg, Germany.